An interesting case of life-threatening COVID-19 pneumonia

Abstract

COVID-19 pneumonia requires intensive care unit admission in approximately 5% of patients. The treatment options are all experimental. We report a case of life-threatening COVID-19 pneumonia with cytokine release syndrome who had successful outcome with tocilizumab.

Keywords

• covid-19
• cytokine release syndrome
• tocilizumab